Ras proteins are signal transducers for many cellular responses. However, it is not well established whether Rassignaling also contributes to apoptosis. We have constructed H-Ras R12 -transformed Rat1 fibroblasts using tetracycline operator/repressor (TetO/TetR)-based conditional vectors. Rat1/TetO-Ras R12 (Rat1-Ras) cells produced high levels of HRas R12 protein and exhibited oncogenic transformation. Treatment of Rat1-Ras cells with 0.1% serum triggered massive apoptosis. Rat1-Ras cells expressed increased basal activities of extracellular response kinase (ERK) and p46/p54 stress-activated protein kinase/c-Jun NH 2 -terminal kinase (SAPK/JNK). Interestingly, Ras-dependent apoptosis correlated with further persistent activation of both p46 and p54 SAPK/JNK and concurrent inhibition of ERK. Differential modulation of SAPK/JNK and ERK was not detected in tetracycline-treated cells that did not commit apoptosis. Furthermore, two Bcl-x related proteins of 15 kDa and 18 kDa were highly induced in apoptotic Rat1-Ras cells. Our results establish a direct role for Ras in apoptosis, and suggest a functional relationship between H-Ras, SAPK/JNK, ERK and Bcl-x in regulating apoptosis.
Introduction
Recent investigations suggest that there is an integrated coregulation of proliferative and apoptotic signal transduction pathways. This conclusion is based on the observations that several oncogenes can influence the cellular processes that govern both proliferation and death. For example, overexpression of the c-Myc (Myc) gene in untransformed fibroblasts or T-lymphocytes causes increased cell proliferation and transformation; however, cells overexpressing Myc also exhibit an increased susceptibility to apoptosis in response to serum starvation or growth factor withdrawal (Marcu et al, 1992; Evan et al, 1992; Shi et al, 1992) . Similarly, overexpression of cellular E2F-1 (Qin et al, 1994; Wu et al, 1994) or viral E1A (Debbas and White, 1993; Lowe and Ruley, 1993) promotes forced cell cycle entry and apoptosis in serum-starved cells. Thus, these oncogene products can cause either mitosis or apoptosis, depending on the availability of critical growth stimuli. By contrast, the Bcl-2 protooncogene functions as a repressor of apoptosis (Tsujimoto et al, 1985; Korsmeyer, 1992) . Elevated expression of Bcl-2 in tumor cells contributes to neoplastic cell expansion by preventing normal cell turnover due to apoptosis, rather than by accelerating the rate of cell proliferation (Vaux et al, 1988; Reed, 1994) . Molecular cloning of homologous Bcl-2 genes has led to the identification of several additional family members. Among these, the Bcl-x (Boise et al, 1993) and Bax (Oltvai et al, 1993) genes are best characterized. The Bcl-x gene produces two distinct proteins (Bcl-x L and Bcl-x S ) as a result of alternative RNA splicing (Boise et al, 1993) . While Bcl-x L has a similar death inhibition function as Bcl-2, Bcl-x S and Bax both promote apoptosis (Boise et al, 1993; Oltvai et al, 1993) .
The mammalian Ras family of small guanine-nucleotidebinding proteins are conserved cellular signal transducers. Genetic mutations that cause Ras to be constitutively activated have been found in many types of human cancer, as well as in experimental tumors induced by various carcinogens (Barbacid, 1990; Bos, 1989) . Ras-mediated signaling pathways are critical for a wide array of mitogenic and differentiation responses stimulated by growth factors and hormones (Barbacid, 1987; Greenwald and Rubbin, 1992; McCormick, 1995) . Recent studies suggest that Ras may also be important in the regulation of cellular survival or death. In support of its role in cell survival, overexpression of activated Ras gene in hematopoietic cells leads to suppression of apoptosis (Kinoshita et al, 1995; Terada et al, 1995) . Activated H-Ras also suppresses apoptosis in intestinal epithelial cells grown in suspension (Rak et al, 1995) . In contrast, two studies have shown that ectopic expression of oncogenic H-Ras in murine fibroblasts confers susceptibility to apoptosis caused by serum starvation (Tanaka et al, 1994) or exposure to TNF-a . Effects on cell death have also been described for other Ras related proteins such as RRas (Wang et al, 1995) and Rho (Jimenez et al, 1995) . In a recent report Kauffmann et al (1997) showed that activated Ras can also enhance apoptosis triggered by c-Myc. These authors further suggested that Ras-signaling may lead to activation of separate PI(3) kinase pathway and Raf1 pathway, which may have opposing effects on cell survival and death. Taken together, despite different outcomes were observed from different cellular systems, it seems likely that both cell death and survival may ultimately depend on a balance between multiple pathways linked to Ras (Tanaka 1994; Chen and Faller, 1995; Kauffmann et al, 1997) .
Ras-signaling pathways are mediated in part through two parallel serine/threonine mitogen activated protein kinases (MAPKs) pathways (Karin, 1995) . In addition to the Raf-MEK-ERK cascade required for cell growth and differentiation, a second MAP kinase pathway termed the stress activated protein kinase/c-Jun N-terminal kinase (SAPK/ JNK) cascade has recently been identified. Signaling through the MEKK-SEK1-SAPK/JNK cascade can be activated in response to mitogens and several stress stimuli and have diverse effects on cell growth (Hibi et al, 1993; Derijard et al, 1994; Kyriakis et al, 1994; Han et al, 1994) . Similar to the ERK MAP kinases, activation of SAPK/JNK requires dual phosphorylation on conserved threonine and tyrosine residues (Cobb and Goldsmith, 1995) . Because activation of SAPK/JNK can be triggered by several stimuli that cause apoptosis, studies have been directed to examine its roles in modulating apoptotic signaling pathway. Recent reports suggest that SAPK/ JNK cascade could positively influence apoptosis in response to several stress signals (Xia et al, 1995; Verheij et al, 1996; Cuvillier et al, 1996) .
Although effects of Ras on apoptosis has been documented, the biochemical and molecular changes underlying this phenomenon are largely unknown. To examine the role of Ras and its signaling pathways in modulating apoptosis, we have constructed Rat1 fibroblast cell lines that were transformed by oncogenic H-Ras R12 using conditional expression (Gossen and Bujard, 1992) . In the present study, we show that activated H-Ras R12 is a potent inducer of apoptosis in response to serum starvation. Moreover, Ras-dependent apoptosis likely involves differential regulation of SAPK/JNK and ERK pathways, and induction of isoform(s) of Bcl-x. gene required transactivation by a chimeric transcription factor TetR-VP16, which consists of the bacterial tetracycline repressor (TetR) fused to the transcriptional activation (TA) domain of a viral transcription factor VP16 ( Figure 1A ) (Gossen and Bujard, 1992) . By cotransfection of these plasmids into Rat1 cells, we obtained several Rat1/TetO-HRas R12 (Rat1-Ras) cell lines. In the absence of tetracycline, these cells produced high levels of H-Ras R12 protein, whereas treatment with 2 ± 5 mM tetracycline prevented expression of H-Ras R12 ( Figure 1B) . Thus, ectopic expression of H-Ras
Results

Transformation of
R12
in these cells could be tightly controlled by tetracycline. Rat1-Ras cells displayed a distinct growth morphology and transformed cellular phenotype when cultured in the absence of tetracycline. Cells in monolayer culture exhibited elongated spindle-shape that attached poorly to culture plates ( Figure 2A ). Upon reaching confluency, these cells formed high numbers of foci due to loss of contact growth inhibition. Further confirmation of the oncogenic transformation of these cells by H-Ras R12 was demonstrated by the ability of these cells to grow in an anchorageindependent manner. As shown in Figure 2B , high levels of H-Ras R12 in these cells led to efficient colony formation and growth in soft agar. As expected, these morphological and
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-transformed Rat1 fibroblasts undergo rapid apoptosis following serum deprivation Further analysis of growth characteristics of Rat1-Ras cells revealed that these cells were extremely sensitive to lowserum growth conditions. Initial observations for 12 independent clones indicated that they all exhibited reduction in viability after exposure to media with 0.1% serum. Cell death caused by low-serum stress was measured in three independent clones (clones 15, 29 and 38) by trypan-blue exclusion ( Figure 3) . Upon serum withdrawal, all three clones showed transient small increases in cell number, followed by rapid and extensive cell death. By 72 h, 50 ± 70% of the cells were dead relative to Day 0 (Figure 3) , and the entire culture died within 4 ± 5 days (not shown). Cell death was completely dependent on overexpression of H-Ras R12 , since death could be prevented with 2 mM tetracycline prior to serum withdrawal (Figure 3 ). The observed cell death was not due to TetR-VP16 chimeric protein because its expression was constitutive in both tetracycline-treated and -untreated Rat1-Ras cells. Response to low-serum by Rat1-Ras cells treated with tetracycline was similar to that by parental Rat1 cells. In both these cases there was a small increase in cell numbers
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+TET. Anchorageindependent growth of Rat1-Ras cells. Soft agar growth experiments were performed in 24-well dishes as described in Materials and Methods. Tetracycline (10 mM) was added to subsets of wells. After incubation for 14 days, the number of colonies in each well was determined by a computerized image analyzer. Average colony numbers were derived from 10 ± 12 replicate wells Figure 3 Low-serum induced cell death of Rat1-Ras cells. Rat1-Ras clones and corresponding tetracycline-treated (+Tet) cells (pretreated with tetracycline for at least 5 ± 7 days before the initiation of experiments) were plated in 6-well dishes in complete media with 10% serum, and then switched to media containing 0.1% serum 24 h later. On day 0 (the day switching to low-serum) and 2, 3 and 4 days after low-serum exposure, culture supernatants were removed, and cells were collected by trypsinization. Viable cells from each well were counted by trypan blue exclusion. Average cell numbers were derived from triplicate wells within the same experiment, and were expressed as relative percent survival compared to the cell numbers on day 0. Data presented are averages of three independent experiments with its associated standard deviation (S.D.) followed by growth arrest, but not cell death ( Figure 3 , not shown).
RAT1/TETO-H-RAS CLONES
To examine whether Ras-dependent cell death in lowserum occurs by apoptosis, Rat1-Ras clones 29, 38 and corresponding tetracycline-treated cells were stressed by exposure to 0.1% serum for 3 days. Cells were then stained with bisbenzimide H33258 for microscopic examination ( Figure 4A ). In the presence of tetracycline, there was minimal cell death resulting from low-serum stress as indicated by only background staining of normal nuclei. In contrast, clones of Rat1-Ras cells exposed to low-serum in the absence of tetracycline showed massive cell death with large numbers of brightly stained, condensed, and fragmented nuclei ( Figure 4A ). Electrophoresis of genomic DNA showed nucleosomal laddering for Rat1-Ras clones in the absence of tetracycline ( Figure 4B ). In contrast, tetracycline-treated Rat1-Ras cells showed only low levels of random DNA degradation without distinct DNA laddering ( Figure 4B ). This background degradation of DNA in tetracycline-treated cells in this experiment was more noticeable in clone 29 than clone 38, which may be due to an insufficient repression of H-Ras R12 under these conditions. Experiments with clone 15 showed similar result (not shown). From these studies we conclude that apoptosis is the primary mode of low-serum induced cell death in Rat1-Ras cells.
Persistent activation of p46 and p54 SAPK/JNK and inhibition of ERK in Ras-dependent apoptosis
Previous reports have suggested a potential involvement of SAPK/JNK pathway in regulating apoptosis, and it has been documented that Ras-signaling is mediated in part through ERK and SAPK/JNK members of the MAP kinase family. We Figure 4 Ras-dependent cell death by apoptosis. (A) Cells of Rat1-Ras clones 29, 38 and tetracycline-treated (+Tet) cells were plated in 6-well dishes, switched to 0.1% serum for 3 days, and then photographed. For each cell line, left panels, phase-contrast view (total magnification: 4006); right panels, nuclear morphology after staining cells with 1 mg/ml bisbenzimide H33258 (total magnification: 4006). Cells were incubated either without (upper panels) or with 5 mM tetracycline (lower panels). (B) Genomic DNA was isolated from clones 29 and 38 either grown in 10% serum or 0.1% serum as described in Materials and Methods. Equal amounts of total DNA were size fractionated in a 2.0% TAE-agarose gel and visualized by ethidium bromide staining therefore examined the potential involvement of MAPK family of protein kinases in Ras-dependent apoptosis. We measured individual kinase activity from cells that were stressed with low-serum for various times. For each time point, protein lysates were prepared from total cells (pooled from adherent and floating cells). Equal amounts of lysates were subjected to immunoprecipitation with antibodies raised against p46 SAPK/JNK, p54 SAPK/JNK, p38 MAPK and ERK. Kinase activities were then measured in an immunocomplex kinase assay with added protein substrate. The results with clone 29 Activation of SAPK/JNK and inhibition of ERK during Ras-dependent apoptosis. (A) Rat1-Ras clone 29 and tetracycline-treated (+Tet) cells were plated in 6-well dishes in complete media with 10% serum, and then switched to media with 0.1% serum. Protein lysates were prepared from total cell population at indicated time points. Equal amounts of protein lysates (200 mg) were subjected to immunoprecipitation with kinase-specific antibodies as described in Materials and Methods. p46/p54 SAPK/JNK, p38 MAPK and p44/p42 ERK kinase activity was measured in the immunocomplex with added 5 mg recombinant substrate protein GST-c-Jun (1 ± 79), Phas I and MBP, respectively, in the presence of [g 32 P]ATP. Phosphorylation of substrate proteins was examined after SDS ± PAGE by autoradiography. An autoradiograph of the gel is presented, and specific signals corresponding to active kinases were also quantitated by phosphor-imaging analyzer. (B) Lysates (100 mg) prepared similarly as in (A) were subjected to immunoblotting with indicated kinase-specific antibodies to determine the kinase protein levels. (C) Rat1-Ras clones 29 and 38 (7/+Tet) were grown in media with 10% serum and metabolically labeled with 32 P-phosphate before protein lysates were prepared. Equal amounts of lysates (200 mg) were immunoprecipitated with p46 SAPK/JNK antibody (Sc-474). Phosphorylation of p46 SAPK/JNK was detected by autoradiography after SDS ± PAGE. The arrow indicates the in vivo phosphorylated p46 SAPK/JNK, which was increased in H-Ras R12 -expressing cells ( Figure 5A ) indicated that Rat1-Ras cells expressed a significantly increased basal levels of active p46 SAPK/JNK and ERK compared to tetracycline-treated cells. The basal activity for p54 SAPK/JNK was also higher in H-Ras R12 -expressing cells. Upon low-serum treatment, Rat1-Ras cells showed a further induction (fourfold) of p46 SAPK/JNK by 48 h, followed by a decrease at 64 h ( Figure 5A ). Similarly, p54 SAPK/JNK was also highly activated in low-serum treated Rat1-Ras cells, although with a more persistent kinetics than p46. The maximal p54 activation (12-fold) was seen by 48 h and remained high at 64 h ( Figure 5A ). In contrast to Ras R12 -overexpressing cells, activation of p46 or p54 SAPK/JNK was not detected in tetracycline-treated Rat1-Ras cells after lowserum stress ( Figure 5A ). These results indicated that activation of p46 and p54 SAPK/JNK were both specific to H-Ras R12 -expressing cells and that peak accumulations of SAPK/JNK preceded maximal apoptosis observed between three to four days after low-serum stress (Figures 3 and 5A) . Similar experiments indicated that unlike p46/p54 SAPK/JNK, activities for p38 MAPK and ERK were not induced in Rat1-Ras cells following low-serum stress ( Figure 5A ). Rather, we observed a small but reproducible decrease (2 ± 3-fold) in ERK activity in Rat1-Ras cells after 2 ± 3 days in low-serum ( Figure 5A , not shown). Thus, it appears that while overexpression of H-Ras R12 causes increased basal levels for both SAPK/JNK and ERK, these two classes of MAPK family are regulated quite differently in Rat1-Ras cells after serum withdrawal. This pattern of differential modulation of SAPK/JNK and ERK was also observed with low-serum stressed apoptosis in Rat1-Ras clone 38 (not shown).
B
In parallel experiments, we performed Western blot analysis to determine the expression of these kinases. Equal amounts of lysates were fractionated in SDS ± PAGE and immunoblotted with antibodies for p46 SAPK/JNK, p54 SAPK/JNK, p38 MAPK and p44/p42 ERK ( Figure 5B ). These experiments demonstrated that the protein levels for p46, p54 SAPK/JNKs, p38 MAPK and ERK were similar between tetracycline-treated and -untreated Rat1-Ras cells, and they remained relatively constant after treatment with low-serum. The Western blot of ERK revealed that while the level of p44/p42 ERKs remained similar among different samples, there was a basal level increase in phosphorylated forms of p44/p42 ERK in Rat1-Ras cells relative to tetracycline-treated cells as indicated by reduced electrophoretic mobilities, which likely account for an elevated ERK activity in these cells ( Figure 5A , 0 h). Noticeably, lowserum exposure to Rat1-Ras cells caused a decrease of phosphorylated p44 and p42 ERK, which might be consistent with a reduction in kinase activity ( Figure 5A , 48 h, 64 h). To determine whether the increase of basal SAPK/JNK activity in Rat1-Ras cells was due to increased phosphorylation of SAPK/JNK itself, lysates were prepared from cells grown in 10% serum and metabolically labeled with 32 P-phosphate. Immunoprecipitation of in vivo labeled lysates revealed that both Rat1-Ras clones 29 and 38 expressed increased basal levels of phosphorylated p46 SAPK/JNK compared to tetracycline-treated cells ( Figure  5C ). Therefore, as previously proposed by others, activation of SAPK/JNK in Rat1-Ras cells likely involves upstream kinases through phosphorylation.
Induction of 15 kDa and 18 kDa isoform(s) of Bcl-x during apoptosis
To further examine whether Ras-mediated apoptosis involves several previously described apoptosis modulators such as p53, Bax, and Bcl-x, we performed Western blot analysis. Cellular p53 protein level was not significantly altered in Rat1 cells after transformation by H-Ras R12 , nor was p53 selectively accumulated after exposure of Rat1-Ras cells to low-serum stress (not shown). However, Western blot analysis of low-serum-stressed Rat1-Ras clones showed a high induction of two closely-migrating proteins recognized by a Bcl-x monoclonal antibody. These Bcl-x related proteins from both clone 29 ( Figure 6A ) and clone 38 (not shown) had apparent molecular mass of 15 kDa and 18 kDa, and were induced after 48 h of low-serum treatment. Induction of both proteins was specific to Ras-transformed cells undergoing apoptosis, since these proteins were minimally detected in tetracycline-treated cells ( Figure 6A , lower panel). The 30 kDa long form of Bcl-x (Bcl-x L ) remained relatively constant during low-serum response in these cells ( Figure  6A , upper panel). Because the 15 kDa and 18 kDa proteins detected in apoptotic Rat1-Ras cells were smaller than the previously reported Bcl-x S (21 kDa), we carried out immunoprecipitation experiments using two additional anti-Bcl-x polyclonal antibodies. As shown in Figure 6B (lanes 1 and 2), both the 15 kDa and 18 kDa proteins were specifically precipitated with both antibodies. Therefore, it is likely that both p15 and p18 proteins are isoform(s) of Bcl-x. Alternatively, they may be products of novel gene(s) that are highly homologous to Bcl-x.
In parallel experiments, expression of Bax protein was also examined. By immunoblot analysis, we could identify two Bax isoforms (21 kDa and *18 kDa), present at low levels in the tetracycline-treated Rat1-Ras cells. Overexpression of H-Ras R12 in both Rat1-Ras clone 29 ( Figure  6C ) and clone 38 (not shown) resulted in an increase of basal level expression of the 18 kDa Bax protein. After exposure to low-serum stress, p18 Bax was found to be present at high levels in both tetracycline-treated anduntreated Rat1-Ras cells, while a slower and moderate increase of p21 Bax was detected in apoptotic Rat1-Ras cells ( Figure 6C ).
Discussion
In the present study we have examined the effect of overexpression of oncogenic H-Ras R12 in Rat1 fibroblasts on susceptibility to low-serum induced apoptosis. Using Rat1 cells with conditional expression of H-Ras R12 , we have established a clear correlation between deregulated oncogenic H-Ras and low-serum-induced apoptosis. Our evidence is in contrast to several reports that Ras suppresses apoptosis (Kinoshita et al, 1995; Terada et al, 1995; Rak et al, 1994) . However, other studies with cellular systems more similar to ours have shown that constitutive Ras activation can promote apoptosis. Oncogenic H-Ras causes apoptosis in murine embryo fibroblasts after serum withdrawal (Tanaka et al, 1994) and confers susceptibility to TNF-a induced apoptosis in 10T1/2 murine fibroblasts . Activated R-Ras increases apoptosis in 32D.3 murine pre-B cells in response to IL-3 removal (Wang et al, 1995) . Furthermore, overexpression of wild-type Rho induces apoptosis in NIH3T3 cells following serum withdrawal (Jimenez et al, 1995) . Consistent with a connection between the Ras-signaling pathway and apoptosis in vivo, p120-rasGAP deficient mice display extensive neuronal apoptosis (Henkemeyer et al., 1995) . The basis for differential outcomes of death or survival resulting from Ras-overexpression in cultured cell systems has not been determined, but likely depend on a balance of cellular background and multiple pathways linked to Ras-signaling (Tanaka et al, 1994; Chen and Faller, 1995; Kauffmann et al, 1997) .
In Rat1-Ras cells, the effects of activated H-Ras on apoptosis were associated with the transformed cell phenotype. These cells exhibited a dramatically altered monolayer growth morphology, are capable of anchorageindependent growth, and responded to low-serum stress by inducing apoptosis. Although oncogenic H-Ras R12 overexpression results in both cellular transformation and elevated susceptibility to apoptosis, some downstream events leading to apoptosis are likely to be distinct from those regulating cellular proliferation and transformation. Consistent with this notion, have suggested that TNF-a induced apoptosis in H-Rastransformed 10T1/2 cells is not directly mediated by Ras However, SAPK/JNK and ERK were regulated very differently in Rat1-Ras cells after treatment with lowserum. While ERK activity was decreased after 2 ± 3 days of low-serum treatment, both p46 and p54 SAPK/JNK activities were significantly further induced, with peak accumulations seen approximately 2 days after low-serum stress. It was noted that although the basal activity of p54 was low, its induction by low-serum was somewhat more persistent than p46, which may suggest that the biochemical steps for activating p46 and p54 in low-serum treated Rat1-Ras cells are not identical. In contrast to Rat1-Ras cells, exposure of tetracycline-treated Rat1-Ras cells to low-serum did not cause detectable activation of p46 or p54 SAPK/JNK.
The distinct activation pattern for SAPK/JNK in Rat1-Ras cells may contribute to the regulation of apoptosis. Although our results do not constitute a proof for functional involvement of SAPK/JNK in apoptosis, this speculation is consistent with two aspects of the apoptotic death in Rat1-Ras cells. First, low-serum-induced SAPK/JNK activation only occurred in the H-Ras R12 -overexpresing cells undergoing apoptosis but not in tetracycline-treated Rat1-Ras cells that did not commit active cell death. Second, the maximal SAPK/JNK activity was seen approximately 2 days following low-serum stress, which occurred prior to maximal apoptosis observed between 3 ± 4 days after low-serum stress. Thus, it is possible that selective activation of SAPK/JNK cascades may play a role in conferring cellular susceptibility to apoptosis or in the induction of active death program. Because ERK activity was decreased after lowserum stress, it is also possible that the differential activation of SAPK/JNK and concurrent inhibition of ERK may collectively contribute to the regulation of cell death. Consistent with these speculations, a recent study correlated activation of SAPK/JNK and inhibition of ERK with apoptosis in PC12 cells in response to NGFwithdrawal (Xia et al, 1995) . SAPK/JNK activation has also been implicated in modulating apoptosis in Jurkat Tcells after exposure to lethal doses of g radiation , and in U937 monoblastic leukemia cells stressed by ceramide (Verheij et al, 1996; Cuvillier et al, 1996) . To further strengthen a connection between SAPK/JNK and apoptosis, dominant-negative kinase mutants inhibit apoptosis in PC12 cells after NGF-withdrawal (Xia et al, 1995) and radiation-induced apoptosis in 293T cells .
Several external stress stimuli can activate SAPK/JNK pathway (Hibi et al, 1993; Derijard et al, 1994; Kyriakis et al, 1994; Han et al, 1994) . Our results indicated that signaling through SAPK/JNK cascade in Rat1 cells can also be influenced by withdrawal of serum in combination with deregulated Ras via a yet to be identified mechanism. Unlike the rapid activation (minutes to hours) by several well studied SAPK/JNK inducers such as UV irradiation and proinflammatory cytokines, induction of SAPK/JNK after serum reduction in Rat1-Ras cells was a much slower and more persistent response. It is likely that the low-serum dependent activation of SAPK/JNK may be mediated by molecular steps that are different from those responding to UV or inflammatory cytokines, and may involve SAPK/JNK activator(s) or inhibitor(s) whose regulation was altered by deregulated Ras-pathway. It is interesting to speculate that if SAPK/JNK indeed participates in critical steps of apoptosis in cells expressing deregulated Ras, then selective modulation of this cascade by Ras action may provide a molecular basis for elevated susceptibility to apoptosis in Ras-transformed cells. Future studies are needed to determine directly the functional relevance of SAPK/JNK in Ras-dependent apoptosis in Rat1 fibroblasts.
Proteins of the Bcl-2 family play important roles in regulating apoptosis. High level expression of Bcl-2 has been found in several types of human cancer and contributes to tumorigenesis by preventing apoptosis (Tsujimoto et al, 1985; Vaux et al, 1988) . In vitro, Bcl-2 has been shown to inhibit apoptosis induced by diverse stimuli (Vaux et al, 1988; Korsmeyer, 1992; Boise et al, 1993; Reed, 1994) . The p21 Bax protein has been postulated to be a positive modulator of apoptosis by sequestering Bcl-2 in Bcl-2/Bax heterodimers (Oltvai et al, 1993) . Recently, an isoform of Bax, p18 Bax, was detected in B-cell chronic lymphocytic leukemia cells that were induced for apoptosis by a camptothecin related drug (Thomas et al, 1996) , and this p18 Bax was absent in drugresistant cells. We have observed that overexpression of HRas R12 in Rat1-Ras cells caused a marked increase of basal expression of p18 Bax. However, accumulation of p18 Bax occurred in both tetracycline-treated and -untreated Rat1-Ras cells after exposure to low-serum, which apparently did not correlate with the status of apoptosis. Low-serum stress caused a moderate increase of p21 Bax in apoptotic Rat1-Ras cells. It remains to be determined whether elevated basal expression of p18 bax or low-serum induced increase of p21 Bax in Rat1-Ras cells contributes to apoptosis.
A new observation from this study is a specific connection between Ras-dependent apoptosis and induction of two isoform(s) of Bcl-x or novel gene product(s) that are highly homologous to Bcl-x. The Bcl-x gene has previously been shown to encode two proteins, Bcl-x L (30 kDa) and Bcl-x S (21 kDa), as a result of alternative RNA splicing (Boise et al, 1993) . While Bcl-x L can inhibit apoptosis (Boise et al, 1993; Dole et al, 1995; Schott et al, 1995) , overexpression of Bcl-x S by cDNA expression vector restores apoptosis in the presence of Bcl-2. Furthermore, transfected Bcl-x S induces apoptosis in cultured human tumor cells Sumantran et al, 1995) . The two proteins detected by Bcl-x antibodies in apoptotic Rat1-Ras cells had apparent molecular mass of 15 kDa and 18 kDa. Although the sequence for the p15 and p18 proteins have not been determined, our observations suggested that these protein species may be derived from the Bcl-x S described previously or from new isoform(s) of Bcl-x. Our data support a role for p15 and p18 Bcl-x S in Ras-dependent apoptosis in Rat1 cells. To our knowledge, these results provided the first experimental evidence that during the induction of Ras-dependent apoptosis, the level of cellular Bcl-x S or related isoform(s) is specifically induced. These observations support the previous hypothesis that Bcl-x S may function as an apoptosis inducer. It has been suggested that the ratios of Bcl-x L /Bcl-x S or Bcl-2/ Bcl-x S may be critical for induction of apoptosis. It is possible that elevated p15 and p18 Bcl-x S in Rat1-Ras cells may alter the balance between these heterodimers. Consistent with this prediction, high levels of Bcl-2 in Hras-transformed 10T1/2 cells and in R-Ras-overexpressing 32D cells (Wang et al, 1994) inhibit apoptosis, perhaps by establishing a new balance between heterodimers that favors cell survival.
The findings of this study support the notion that elevated susceptibility to apoptosis is an intrinsic feature of transformed cell types expressing deregulated oncogenes such as Myc and Ras. Oncogenic Ras mutations have been found in many types of human cancer. In vitro, Ras alone is not capable of transforming primary cells, and cooperation by other cellular or viral oncogenes with Ras for transformation of a variety of primary cells has been well documented (Weinberg, 1989; Marshall, 1991) . The functional connection between Ras and cellular apoptosis strongly suggests that deregulated Ras oncogene can also cooperate with apoptosis modulators. Genetic alterations in tumors such as loss of p53 tumor suppressor, or elevated expression of death suppressors Bcl-2 or Bcl-x L may cooperate with Ras in tumorigenesis. In this regard, oncogenic H-Ras has been shown to transform primary embryo fibroblasts that lack p53 tumor suppressor or transcription factor IRF-1 presumably by inhibiting H-Rasinduced apoptosis (Tanaka et al, 1994) . Our results present a beginning for elucidating the molecular changes that may modulate apoptosis in tumor cells with deregulated Ras oncogene. Furthermore, since apoptosis in tumor cells is likely a process that can be both positively and negatively regulated by many cancer genes, a better understanding of the molecular events influenced by these gene products may have important implications for cancer therapy.
Materials and Methods
Plasmid constructions
Full-length H-Ras R12 cDNA was kindly provided by Dr Geoffrey Cooper (Dana Farber Cancer Institute, Boston, MA). The pTetO-HRas R12 was constructed by inserting full-length H-Ras R12 cDNA into the BamHI site of PUHG10-3 (Gossen and Bujard, 1992) . The pUHDTetR-VP16/Neo (pTetR-VP16/Neo) was constructed by inserting a XhoI/SalI fragment containing the neomycin resistance gene (Neo R ) cassette from pMC1Neo/PA (Stratagene, La Jolla, CA) into the XhoI site of PUHD15-1 which contains the CMV-TetR-VP16 (Gossen and Bujard, 1992) .
Cell culture and generation of stable cell lines
Rat1 cells (kindly provided by Dr Michael Newman, Sandoz Pharmaceuticals, East Hanover, NJ) were cultured in Dulbecco's Modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) (BioWhittaker, Walkersville, MD) at 378C containing 5% CO 2 . Rat1/TetO-H-Ras R12 (Rat1-Ras) stable cell lines were constructed by cotransfections of pTetO-H-Ras R12 and pUHDTetR-VP16/Neo into Rat1 cells by electroporation (0.3 kV/500 mF). Transfected cells were selected for neomycin resistance by exposure to 1.0 mg/ml Geneticin (Gibco-BRL, Grand Island, NY) in complete media for 2 ± 3 weeks. Neomycin-resistant (Neo R ) colonies were cloned, expanded, and analyzed for stable, and tetracycline-repressible expression of HRas R12 by immunoblotting. Established Rat1-Ras cell lines were cultured in the same growth media. In the experiments where Rat1-Ras (+Tet) cells were used, Rat1-Ras cells were pretreated with 2 mM tetracycline for at least 5 ± 7 days to suppress H-Ras R12 phenotype before experiments were initiated.
Soft agar colony assay
Rat1-Ras cells were tested for ability to grow in semisolid (soft agar) culture. Assays were performed in 24-well culture dish. The wells were pre-plated with 0.5 ml of bottom media containing 0.8% agar. Cells (not pretreated with tetracycline) were mixed with top layer media containing 0.4% agar, and plated at 2000 cells per well in 0.5 ml with or without 10 mM tetracycline (Sigma Chemicals, St Louis, MO). Cells were incubated for 12 ± 14 days without refeeding. Colonies from each well were counted using a computerized image analyzer (KS400, Kontron Elektronnik) and average values were derived from measurements of 6 ± 12 replicate wells.
Cell death or survival measurements
Rat1-Ras cells (+/7Tet) were seeded at low density in 12-well (2610 4 cells/well) or 6-well (5610 4 cells/well) dishes in DMEM with 10% serum. Culture medium was removed 24 ± 36 h later and replaced with DMEM containing 0.1% serum. At time zero, and at various times after reduction of serum concentration, culture supernatants were removed and the cells were washed once with pre-warmed PBS. Adherent cells were trypsinized, and viable cells were counted by the method of trypan-blue exclusion. Cell survival data were derived from replicate wells within the same experiment. In separate experiments, apoptosis caused by low-serum stress was documented by phase and fluorescence microscopy after staining cells with 1 mg/ml bisbenzimide H33258 (Sigma Chemicals).
DNA fragmentation
Rat1-Ras cells (+/7Tet) were seeded in 6-well dishes, and exposed to DMEM with 0.1% serum as described above. At time zero or 3 days after low-serum addition, all cells (adherent and floating) were collected and lysed in 0.5 ml of lysis buffer containing 10 mM Tris (pH 8.0), 100 mM NaCl, 25 mM EDTA, 0.5% SDS, 100 mg/ml proteinase K. The lysates were incubated at 558C for 4 ± 12 h. After sequential extractions with an equal volume of phenol (16), and phenol:chloroform (16), DNA was precipitated with ethanol, collected by centrifugation, and resuspended in TE buffer containing 10 mM Tris (pH 7.5), 1 mM EDTA, 1 mg/ml RNase A. DNA samples were fractionated by electrophoresis in a 2.0% TAE-agarose gel and visualized by ethidium bromide staining.
Western blotting and Immunoprecipitation
Unless otherwise mentioned, for all experiments involving apoptosis, lysates were prepared from total cell population collected from both adherent and floating cells. For immunoblotting analysis, cells grown in 6-well tissue culture dishes were lysed in a buffer containing 10 mM HEPES (pH 7.5), 150 mM NaCl, 0.25% NP-40, 1 mM sodium vanadate, 1 mM NaF, 10 mg/ml 4-(2-Aminoethyl)-benzenesulfonyl fluoride hydrochloride (AEBSF) and 10 mg/ml aprotinin, centrifuged at 12 0006g for 20 min at 48C to collect cleared lysates, and protein concentrations determined (Bio-Rad Laboratories). Equal amounts (50 ± 100 mg) of protein were resolved by 10 ± 15% SDS-polyacrylamide gel electrophoresis (SDS ± PAGE), and were transferred to nitrocellulose by electroblotting. Immunoblots were probed with panRas antibody (Ab-1, Oncogene Science, OP21). Antibodies for ERK (06-182), p54-SAPK/JNK (06-425) were purchased from Upstate Biotechnology Inc. (UBI) (Lake Placid, NY). Antibodies for p46-SAPK/ JNK (SC-474), p38 MAPK (SC-535, 728) and Bax (SC-526) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Bcl-x immunoblots were probed with anti-Bcl-x monoclonal antibody (Transduction Lab, 22620). Following primary antibody blotting, immunoblots were treated with anti-mouse horseradish peroxidase (HRP)-conjugated antibody (1 : 5000 dilution) and developed using enhanced chemiluminescence (ECL) (Amersham Life Science).
Cell lysates prepared from low-serum treated Rat1-Ras clone 29 were separately immunoprecipitated using two anti-Bcl-x polyclonal antibodies (Transduction Lab., 22630 or Santa Cruz, SC-634), and resulting immunocomplexes were then isolated on protein A Sepharose (Pharmacia Biotech Inc., Piscataway, NJ). Subsequent steps were carried out as described above for Western blot analysis.
Kinase assays
Cell lysates were prepared from total cell population (adherent and floating) are various hours after low-serum stress. Equal amounts (200 mg) of protein were subjected to immunoprecipitation with polyclonal antibodies raised against p46 SAPK (Santa Cruz, SC-474), p54 SAPK (Santa Cruz, SC-527), p38 MAPK (Santa Cruz, SC-728), and ERK (UBI, 06-182). The p46/p54 SAPK/JNK, p38 MAPK or ERK activity was measured in an immunocomplex kinase assay with GST-c-Jun (1 ± 79) (Stratagene), Phas I (Stratagene) or myelin basic protein (MBP) (UBI) as substrates, respectively, following previously established method . Briefly, the immunocomplexes were washed twice with kinase buffer containing 40 mM HEPES (pH 8.0), 20 mM MgCl 2 , 0.1 mM EGTA, 1 mM DTT, 100 mM sodium vanadate. The assays were initiated by addition of 5 mg of substrate protein and 5 mM ATP containing [g 32 P]ATP (2 mCi) in a final volume of 30 ml. The reactions were terminated after 30 min at 308C by addition of Laemmli sample buffer. Phosphorylation of the substrate proteins was examined after SDS ± PAGE by autoradiography.
